Russell H. Wiesner - Concepedia

Author

Russell H. Wiesner

Also Known As

Brian McGrath, R H Wiesner, R WIESNER, R Wiesner, R. H. Wiesner, R. Wiesner, R.H. Wiesner, RUSSELL H. WIESNER, Russell H. Wiesner, Russell Wiesner

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona WinnMed University of California, San Francisco University of Nebraska Medical Center

About

Russell H. Wiesner is an author at Mayo Clinic specializing in medicine, hepatology, and liver transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	2.7K
2	Health Sciences	2	2	218
3	Natural Sciences	2	2	49
4	Nursing	1	1	33
5	Public Health	1	1	33

Russell H. Wiesner

Publications

Citations

H-Index

Page 1

	Year	Citations
The new liver allocation system: Moving toward evidence-based transplantation policy Richard B. Freeman, Russell H. Wiesner, Ann Harper, Liver Transplantation Organ DonationSolid Organ TransplantationPrognosisEvidence-based Transplantation PolicyTransplantation Surgery	2002	719
Ischemic–Type Biliary Complications After Orthotopic Liver Transplantation L. Sanchez-Urdazpal, Gregory J. Gores, Ellen MacDonald Ward, Hepatology	1992	430
Pretransplantation Assessment of the Risk of Lymphoproliferative Disorder Randall C. Walker, W.F. Marshall, John G. Strickler, Clinical Infectious Diseases Posttransplantation Lymphoproliferative DisorderSolid Organ TransplantationImmunologyPathologyPretransplantation Assessment	1995	392
Neutrophil Cytoplasmic Antibodies: A Link Between Primary Sclerosing Cholangitis and Ulcerative Colitis Richard H. Duerr, Stephan Targan, Carol J. Landers, Gastroenterology InflammationAutoimmune DiseaseMucosal ImmunologyGranulocyteImmunology	1991	349
Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. Randall C. Walker, C. V. Paya, W.F. Marshall, PubMed	1995	244
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C Kelly W. Burak, Walter K. Kremers, Kenneth P. Batts, Liver Transplantation	2002	234
Diagnostic Role of Serum CA 19-9 for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis J. CHRISTOPHER NICHOLS, Gregory J. Gores, Nicholas F. LaRusso, Mayo Clinic Proceedings HepatologyBiliary TractBiliary CancerDiagnostic RolePathology	1993	216
Early Identification of Recipients With Progressive Histologic Recurrence of Hepatitis C After Liver Transplantation Sreekumar Raghavakaimal, Alvaro González-Koch, Yaakov Maor‐Kendler, Hepatology	2000	197
Quality of Life Before and After Liver Transplantation for Cholestatic Liver Disease Cynthia R. Gross, Michael Malinchoc, W. Ray Kim, Hepatology Quality Of LifePrimary Biliary CirrhosisCholestatic Liver DiseaseCholangiopathiesAutoimmune Liver Disease	1999	196
Recurrent autoimmune hepatitis after orthotopic liver transplantation Alvaro González-Koch, Albert J. Czaja, Herschel A. Carpenter, Liver Transplantation	2001	191

Page 1